← All companies

APRE

Aprea Therapeutics, Inc.

APRE Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.60

-0.02 -3.60%

Key statistics

from XBRL data in SEC filings

Market cap

$7.40M

Revenue (TTM)

—

Net income (TTM)

-$12.0M

EPS (TTM)

$-1.49

P/E ratio

—

Dividend yield

—

Free cash flow

-$12.9M

Cash

$46.5M

Total assets

$47.6M

Gross margin

—

52-week range

$0.55 – $1.83

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Delisting notice or listing-rule failure Jul 23, 2026 8-K Shareholder vote results Jun 17, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release); Other events May 13, 2026 8-K Regulation FD disclosure Apr 1, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 16, 2026 8-K Results of operations (earnings release); Other events Mar 16, 2026 8-K Other events Feb 18, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Jan 29, 2026 8-K Delisting notice or listing-rule failure Jan 23, 2026 8-K Other events Jan 9, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Dec 9, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release); Other events Nov 12, 2025 8-K Other events Oct 24, 2025 8-K Other events Oct 15, 2025 8-K Other events Sep 8, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Other events Aug 12, 2025 8-K Shareholder vote results Jun 9, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release); Other events May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 25, 2025 8-K Results of operations (earnings release); Director or officer change; Other events Mar 25, 2025 8-K Other events Feb 5, 2025 8-K Results of operations (earnings release); Other events Jan 13, 2025 8-K Entered a material agreement Nov 8, 2024 8-K Results of operations (earnings release); Other events Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Regulation FD disclosure; Other events Oct 23, 2024 8-K Results of operations (earnings release); Other events Oct 9, 2024 8-K Results of operations (earnings release); Other events Aug 12, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Shareholder vote results Jun 20, 2024 8-K Other events Jun 17, 2024 8-K Results of operations (earnings release); Other events May 14, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Other events Apr 10, 2024 8-K Results of operations (earnings release); Other events Mar 26, 2024